161 related articles for article (PubMed ID: 36265823)
1. Retrospective analysis of sepsis in cutaneous T-cell lymphoma reveals significantly greater risk in Black patients.
Hooper MJ; Veon FL; Enriquez GL; Nguyen M; Grimes CB; LeWitt TM; Pang Y; Case S; Choi J; Guitart J; Burns MB; Zhou XA
J Am Acad Dermatol; 2023 Feb; 88(2):329-337. PubMed ID: 36265823
[TBL] [Abstract][Full Text] [Related]
2. Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL).
Allen PB; Switchenko J; Ayers A; Kim E; Lechowicz MJ
Leuk Lymphoma; 2020 Nov; 61(11):2652-2658. PubMed ID: 32558600
[TBL] [Abstract][Full Text] [Related]
3. Mitigation strategies among cutaneous T-cell lymphoma patients with positive
Allen PB; Goyal S; Switchenko J; Tarabadkar E; Pouch S; Parikh P; Palmer A; Martini D; Kim E; Lechowicz MJ
Leuk Lymphoma; 2023 Mar; 64(3):597-604. PubMed ID: 35673767
[TBL] [Abstract][Full Text] [Related]
4. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Outcomes for Hospitalized Patients With Cutaneous T-Cell Lymphoma.
Glinos G; Wei G; Nosewicz J; Abdulla F; Chen PL; Chung C; Kaffenberger BH; Querfeld C; Shinohara MM; Sokol L; Zain J; Kumar A; Seminario-Vidal L
JAMA Dermatol; 2023 Feb; 159(2):192-197. PubMed ID: 36598766
[TBL] [Abstract][Full Text] [Related]
6. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
Amber KT; Bloom R; Nouri K
Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
[TBL] [Abstract][Full Text] [Related]
7. Reply to Wu et al's US SEER analysis of sepsis in Black patients with CTCL.
Hooper MJ; Veon FL; Enriquez GL; Nguyen M; Grimes CB; LeWitt TM; Pang Y; Case S; Choi J; Guitart J; Burns MB; Zhou XA
J Am Acad Dermatol; 2024 Feb; 90(2):e79. PubMed ID: 37797839
[No Abstract] [Full Text] [Related]
8. Extracorporeal photophoresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics and Imiquimod for Cutaneous T-Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure.
Del Guzzo CA; Kojadinovic A; Vinnakota RR; Geskin LJ; Newman JC; Langhoff E; Park YA; Bates SE; Dana AN
Oncologist; 2021 Sep; 26(9):727-e1488. PubMed ID: 33851477
[TBL] [Abstract][Full Text] [Related]
10. Chemical exposures and demographic associations in cutaneous T-cell lymphoma: a large single institution physician validated cohort study.
Ren Z; Chrisman LP; Pang Y; Nguyen M; Hooper MJ; LeWitt TM; Veon FL; Guitart J; Zhou XA
Arch Dermatol Res; 2024 Jan; 316(2):74. PubMed ID: 38236413
[TBL] [Abstract][Full Text] [Related]
11. Lifestyle, demographic and Skindex measures associated with cutaneous T-cell lymphoma: a single institution cohort study.
Nguyen M; LeWitt T; Pang Y; Bagnowski K; Espinosa ML; Choi J; Guitart J; Liszewski W; Zhou XA
Arch Dermatol Res; 2023 Mar; 315(2):275-278. PubMed ID: 35668201
[TBL] [Abstract][Full Text] [Related]
12. T-Cell Receptor Gene Rearrangement Clonality, Flow Cytometry Status, and Associated Outcomes in Early-Stage Cutaneous T-Cell Lymphoma.
Marks JA; Switchenko JM; Martini DJ; Tarabadkar ES; Khan MK; Lechowicz MJ; Allen PB
JAMA Dermatol; 2021 Aug; 157(8):954-962. PubMed ID: 34190977
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
Goyal A; O'Leary D; Goyal K; Patel K; Pearson D; Janakiram M
J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
[TBL] [Abstract][Full Text] [Related]
14. Non-random geographic distribution of patients with cutaneous T-cell lymphoma in the Greater Pittsburgh Area.
Moreau JF; Buchanich JM; Geskin JZ; Akilov OE; Geskin LJ
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046454
[TBL] [Abstract][Full Text] [Related]
15. Disparities in Cutaneous T-Cell Lymphoma Incidence by Race/Ethnicity and Area-Based Socioeconomic Status.
Wiese D; Stroup AM; Shevchenko A; Hsu S; Henry KA
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834276
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen in erythrodermic cutaneous T-cell lymphoma (CTCL) patients.
Emge DA; Bassett RL; Duvic M; Huen AO
Arch Dermatol Res; 2020 May; 312(4):283-288. PubMed ID: 31776647
[TBL] [Abstract][Full Text] [Related]
17. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
19. Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study.
Zhuang TZ; McCook-Veal A; Switchenko J; Niyogusaba T; Tarabadkar ES; Baird K; O'Leary C; Paulino D; Lechowicz MJ; Allen PB
Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):667-673. PubMed ID: 37271662
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous T-cell lymphoma and Staphylococcus aureus colonization.
Nguyen V; Huggins RH; Lertsburapa T; Bauer K; Rademaker A; Gerami P; Guitart J
J Am Acad Dermatol; 2008 Dec; 59(6):949-52. PubMed ID: 18835065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
